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Burton L, Scaife P, Paine SW, Mellor HR, Abernethy L,
Littlewood P, Rauch C. Hydrostatic pressure regulates CYP1A2
expression in human hepatocytes via a mechanosensitive aryl hydro-
carbon receptor-dependent pathway. Am J Physiol Cell Physiol 318:
C889–C902, 2020. First published March 11, 2020; doi:10.1152/
ajpcell.00472.2019.—Approximately 75% of xenobiotics are primar-
ily eliminated through metabolism; thus the accurate scaling of
metabolic clearance is vital to successful drug development. Yet,
when data is scaled from in vitro to in vivo, hepatic metabolic
clearance, the primary source of metabolism, is still commonly
underpredicted. Over the past decades, with biophysics used as a key
component to restore aspects of the in vivo environment, several new
cell culture settings have been investigated to improve hepatocyte
functionalities. Most of these studies have focused on shear stress, i.e.,
flow mediated by a pressure gradient. One potential conclusion of
these studies is that hepatocytes are naturally “mechanosensitive,” i.e.,
they respond to a change in their biophysical environment. We
demonstrate that hepatocytes also respond to an increase in hydro-
static pressure that, we suggest, is directly linked to the lobule
geometry and vessel density. Furthermore, we demonstrate that hy-
drostatic pressure improves albumin production and increases cyto-
chrome P-450 (CYP) 1A2 expression levels in an aryl hydrocarbon-
dependent manner in human hepatocytes. Increased albumin produc-
tion and CYP function are commonly attributed to the impacts of
shear stress in microfluidic experiments. Therefore, our results high-
light evidence of a novel link between hydrostatic pressure and CYP
metabolism and demonstrate that the spectrum of hepatocyte mecha-
nosensitivity might be larger than previously thought.
drug metabolism; hepatocytes; mechanosensitivity
INTRODUCTION
Currently, the intrinsic clearance of a drug is determined in
vitro using hepatoma cell lines, isolated primary hepatocytes,
or enriched subcellular fractions and scaled up to in vivo using
mathematical models (7, 58). However, it is becoming increas-
ingly common for hepatocyte assays to underpredict metabolic
clearance even after empirical corrections (26), with inade-
quate scaling and predictions potentially leading to a poor
transition between in vitro and in vivo environments. Indeed,
with pharmacokinetic and toxicity issues accounting for ~45%
of total failures (63), the drawbacks involved in the use of
isolated primary or hepatic-derived cell lines in generic two-
dimensional culture conditions have become increasingly ap-
parent.
In the body, hepatocytes subspecialize based on their peri-
central positioning within the liver lobule (Fig. 1A), a func-
tional unit within the liver. Hepatocytes closer to the central
vein carry out a higher proportion of drug metabolism (24),
while those closer to the periphery carry out more ammonia
detoxification (Fig. 1B) (3). Thus, determination of the in vivo
signals that contribute to hepatocyte specialization could prove
paramount to elucidation of the underpredictions commonly
observed when data are scaled from an in vitro environment
and to improvement of pharmacokinetic modeling. When
hepatocytes are isolated, they begin to dedifferentiate and
despecialize; both of these events result in lower levels of
drug-metabolizing enzymes (24, 29).
The loss of functionality, specification, and morphology that
occurs when hepatocytes are cultured in vitro is well docu-
mented (2, 56) and has been attributed to the culture conditions
in which they are grown. Attempts to maintain in vivo pheno-
type and functionality by restoring aspects of the in vivo
physiological environment have met with mixed success.
These attempts include controlling CO2 and O2 levels (31),
culturing in three-dimensional tissue culture plates (55), sup-
plementing growth medium with growth factors and cytokines
(13, 54, 56), and coculturing with supportive cell types (59).
More recent studies have found that culturing cells under flow,
with the aim of reproducing the biophysical environment of
hepatocytes, improves the phenotype and expression of meta-
bolic enzymes and transporters (11, 60).
Various methods of flow application used on human, mouse,
and rat hepatocytes and HepG2 cells have demonstrated in-
creased cytochrome P-450 (CYP) 1A1/2 (CYP1A1/2) expres-
sion/activity and albumin production as one of their major
findings (11, 17, 19, 41, 53, 60), with one study even alluding
to the involvement of aryl hydrocarbon receptor (AhR) activa-
tion in the improvement of CYP1A1 in HepG2 cells via shear
stress (41).
All published studies have concurred that altering the bio-
physical properties of cell culture, e.g., using basic hydrody-
namics concepts, is somehow paramount to a better under-
standing of pharmacokinetics. However, how hydrodynamic
stress increases the expression and/or activity of CYP enzymes
at the lobule level is not well understood. Basic hydrodynam-
ics, i.e., Poiseuille’s law, involves at least two fundamental
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physical parameters that balance each other, the pressure gra-
dient and the shear stress, both of which are oriented along the
flow. However, the assumption that the stresses are oriented
only along the flow is legitimate as long as the vessels or
capillaries have solid walls, i.e., the endothelial structure is
solid. On the contrary, living tissues are soft and deformable
under pressure, and, in this context, the notion of “wall stress,”
otherwise known as Laplace’s law, becomes central. The wall
stress results from a pressure applied against the vessel wall,
i.e., with a component perpendicular to the flow. Therefore, the
pressure gradient inside vessels generates a (hydrostatic) pres-
sure with a component perpendicular to the flow at every
position along vessels. As vessels are embedded in tissues, this
suggests that irrigated tissues are under pressure locally at a
magnitude that is a function of vessel density. This point has
been suggested when the lobule vessels are modeled as a
porous system (14), and it is in this context that we aimed to
clarify the role of the hydrostatic pressure in hepatocyte func-
tion. Studies have demonstrated that the capillary hydrostatic
pressure magnitude is ~1–2 kPa (37) and that both hydrostatic
pressure and shear force are capable of modulating the lumen
of circulatory vessels (12). Indeed, experimental work in rat
and mouse liver has shown that the size of the sinusoidal
vessels increases toward the central vein (10, 32, 46, 64),
suggesting that pericentral hepatocytes experience compres-
sion.
Here, we show that hydrostatic pressure is sufficient to
increase albumin production and the expression and activity of
CYP1A2 relative to the nonpressurized control. Additionally,
we demonstrate that the coincubation of pressurized hepato-
cytes with CH223191, an AhR antagonist (8, 66), is sufficient
to inhibit the pressure-mediated increase in CYP1A2, suggest-
ing that AhR could be a mechanosensitive nuclear receptor,
which was later confirmed with a HepG2 reporter cell line. The
effects of biophysical forces on hepatocytes are not completely
novel; however, to the best of our knowledge, no work that
links hydrostatic pressure to improved hepatocyte functionality
has been conducted.
MATERIALS AND METHODS
Ethical considerations. The pig liver tissues were obtained from
animals euthanized for a nonresearch purpose.
Collection and staining of liver tissue. A ~5  5 cm2 section from
three separate freshly slaughtered pigs was collected from Elliot and
Son’s abattoir, immediately placed in formalin buffer, and left over-
night. The tissue was then processed and stained using traditional
methods (21). The vessels, hepatocytes, nuclei, and branch points
were separated based on threshold parameters (see Supplemental
Material, available at https://doi.org/10.6084/m9.figshare.11923188)
in Image-Pro Plus software. The area and centroid coordinates of the
objects were extracted and used to calculate the physical parameters
(see detailed instructions for separation and calculation in Supplemen-
tal Material). Images were taken at 10 magnification with a
DM5000 B microscope (Leica) using a DFC420 camera (Leica) and
Leica Application Suite (LAS) software (version 3.8).
Thawing and seeding cryopreserved human hepatocytes and
HepaRG cells. LiverPool cryoplateable human hepatocytes (10-donor
pool) were purchased from BioVit. Hepatocytes were thawed in a
water bath preheated to 37°C for 1–2 min and placed into a class II
tissue culture hood. The cell suspension was carefully transferred to a
50-mL centrifuge tube containing preheated cryopreserved hepatocyte
recovery medium (Thermo Fisher), which was centrifuged at 100 g for
10 min at 20°C, and the supernatant was discarded. The cell pellet was
resuspended in 5 mL of cryopreserved hepatocyte plating medium
(Thermo Fisher). A 50:50 mix of cell suspension and Trypan blue
solution was pipetted into a Countess cell-counting slide, and cell
viability and concentration were determined automatically via the
Countess automated cell counter. Hepatocytes were made up to 1 
106 cells/mL, and 300 L were seeded into the wells of the pressure
plate (see below). The hepatocytes had been allowed to adhere (~4 h),
and the plating medium was exchanged for William’s E medium
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Fig. 1. A: schematic representation of liver zonation from the periphery to the central vein (CV). B: increases in the gene expressed by hepatocytes located at
the periphery or the center of the liver lobule (3, 6, 23, 25, 32, 33, 35). CYP2F1, cytochrome P-450 (CYP) 2F1; OATP1B3, organic anion-transporting
polypeptide 1B3; TCA, tricarboxylic acid; CAR, constitutive androstane receptor; AhR, aryl hydrocarbon receptor.
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Setting up the pressure plate. Bottoms were removed from poly-
styrene tubes (15.5 mm outer diameter; product no. 55.461, Sarstedt),
and the tubes were fitted into the wells of a 24-well Lumox plate,
which has a gas-permeable membrane and allowed gases to diffuse
through the base of the plate directly to the cell monolayer. The tubes
were glued and sealed to the plate using laboratory-grade silicone
sealant (Dow Corning) and left to cure for 72 h at 37°C. The resulting
construct was sterilized in a UV cross-linker (catalog no. CL-1000,
UVP) at 5,000 J/cm2 for 60 min. The wells were then coated with
collagen I solution from rat tail (5 g/cm2; Sigma Aldrich) and
allowed to dry. The wells were washed five times with 5 mL of sterile
Dulbecco’s PBS (DPBS) buffer, and hepatocytes were seeded at 3 
105 cells/well and left to adhere overnight. On the following morning,
the medium was removed, and the cells were exposed to either 0.28
cm (500 L) of William’s E medium [no-pressure (NP) group] or 10
cm (12.5 mL) of William’s E medium [with-pressure (WP) group] for
a maximum of 72 h, as shown in Fig. 2.
Cell imaging. For imaging, the medium was aspirated, and the
sealant (Dow Corning) was removed using a sterile scalpel blade,
isopropanol, and paper wipes. The tubes were carefully removed from
the plate, and the cell monolayer was washed three times with DPBS
and imaged on an EVOS FL cell-imaging system (Thermo Fisher
Scientific); two images were taken per well. The phenotype of the
hepatocytes was examined nonquantitatively.
Water-soluble tetrazolium salt assay. Water-soluble tetrazolium
salt (WST-1) solution, a mixture of 10% (vol/vol) WST-1 (Roche) and
cell culture medium, was applied to the cell monolayer. After 1 h of
incubation, 80 L of solution were spiked into a 96-well plate, and
optical density at 440 nm was read on a PHERAstar FSX plate reader.
Albumin assay. After incubation, two 300-L samples of medium
from each condition were frozen at 80°C for later analysis. Albumin
was detected using a human albumin sandwich ELISA kit (Abcam)
following the manufacturer’s instructions. Each condition was read in
duplicate for each sample. The absorbance was read on a PHERAstar
FSX plate reader (BMG Labtech).
Lactate dehydrogenase release assay. Lactate dehydrogenase
(LDH) release was assessed calorimetrically using the Pierce LDH
cytotoxicity assay kit (Thermo Fisher Scientific) following the man-
ufacturer’s instructions. Duplicate samples were taken from each well
and averaged, and the absorbance was read on the PHERAstar FSX
plate reader (BMG Labtech). Data are shown as percent viability, with
cells treated with 1 LDH lysis buffer as 0% viable and an empty
well containing collagen and medium as 100% viable. Percent viabil-
ity was calculated using the following equation
Viability %  100 
sample  100% control
0% Control
 100.
Pierce bicinchoninic acid protein recovery assay. After incubation,
the medium was removed, cells were washed three times with DPBS,
and the monolayer was lysed with radioimmunoprecipitation assay
buffer (Thermo Fisher). The protein concentration was calculated
using a Pierce bicinchoninic acid (BCA) protein assay kit (Thermo
Fisher) following the manufacturer’s instructions. Percent protein
recovery was calculated assuming that T0 is equal to 100% as follows




RNA extraction and cDNA conversion. After incubation, the mono-
layer was washed, and RNA was extracted using the SV96 total RNA
isolation system (Promega) via a vacuum-based method following the
manufacturer’s instructions. Once extracted, RNA was stored at
80°C until used. Quantification of RNA concentration was done
using the Quant-IT RNA assay kit following the manufacturer’s
instructions (Invitrogen). cDNA conversion and quantitative PCR
(qPCR) were carried out using the GoTaq two-step RT-qPCR kit
(Promega) with a final concentration of 0.5 ng/L.
Quantitative PCR. GoTaq 2 master mix was mixed with nu-
clease-free water, the gene of interest [CYP3A4, CYP1A2, CYP2B6,
CYP2C9, CYP2D6, aldehyde oxidase 1 (AOX1), hypoxanthine-gua-
nine phosphoribosyltransferase 1 (HPRT1), or GAPDH (TaqMan
Gene Expression Assay, Thermo Fisher Scientific], and cDNA tem-
plate at a ratio of 10:7:1:2 in an RNase/DNase-free tube. The final
volume of 20 L containing 1 ng of cDNA stock was added to each
well of the qPCR multiwell plate (Agilent). Each condition was
triplicated: the plate included triplicates of no-reverse transcriptase
(NRT) and no-template controls, which contained 2 L of nuclease-
free water in the place of the cDNA template. The probe-based dye
Hepatocytes
0.5 mL of media (NP 
group)
10 cm above NP 
group






Oxygen Permeable membrane 
Fig. 2. Schematic of the custom-made pressure plate. NP, no pressure.
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setting and the quick cycle parameters were used for the AriaMx
real-time PCR system (Agilent). Data were collected, exported, and
processed using the 2CT method (49). HPRT and GAPDH stabil-
ity was assessed by visual comparison of cycle thresholds (CT) and
standard deviations; the more stable (in all cases, HPRT) was used as
the housekeeping gene.
P450-Glo metabolism assay. Pressure was removed after 48 h, and
the cell monolayer was washed three times with DPBS. The cells were
then dosed with the appropriate luciferin conjugate substrate for 45
min. The solution was mixed 1:1 with luciferin detection reagent and
read using the luminescence detection settings on the PHERAstar
FSX plate reader (BMG Labtech). The cell monolayer was washed
and lysed, and a protein assay was conducted as described above.
The luminescence value was divided by total protein and displayed
as increase in CYP activity relative to the NP group. Several
pressure points were tested for their effects on metabolic activity
(see Supplemental Fig. S1, available at https://doi.org/10.6084/
m9.figshare.11923194)
AhR induction assay. Pressure was applied as previously described,
but medium was supplemented with 0.2% DMSO (vehicle), 50 M
omeprazole (Sigma Aldrich), or 10 M CH223191 (Sigma Aldrich)
and exchanged every 24 h. After the 48-h incubation period, pressure
was removed, and CYP1A2 expression and activity were assayed by
P450-Glo and qPCR, as previously described.
DRE-1A2 AhR reporter cell line. The DRE-1A2 HepG2-derived
reporter cell line was purchased from Puracyp, and luciferin-1A2 was
purchased from Promega. A CYP1A2 activity and AhR activation
assays were conducted following the manufacturer’s protocol.
Statistics. Data were assessed for normality using the Anderson-
Darling test and visually by a Q-Q plot. Variance was assessed using
Levene’s test, and data that did not appear normal were log-trans-
formed and reassessed.
Linear regression of histology data was checked for a significant
difference (P  0.05) from an intercept-only model (i.e., the x
parameter had no impact) using the F test. P  0.05 was considered
statistically significant.
Statistics on cell-based assays were conducted by a two-way
ANOVA followed by Bonferroni’s post hoc test or, when comparing
only two groups, Student’s unpaired t test. P  0.05 was considered
statistically significant.
RESULTS
Determination of biophysical parameters of the liver lobule
relative to its pericentral positioning. Pig liver tissue was used
to assess the structure and physical parameters of the liver
lobule. Pig tissue was chosen due to easy access to healthy
liver tissue, which is important because disease states such as
cirrhosis have been shown to increase the stiffness of liver
tissue from between 0.3 and 0.6 kPa to a maximum of 12 kPa
(23), which could alter physical properties. Additional consid-
eration included tissue cost and closer similarity of pig than
either rat or mouse liver to human liver (1). Use of thresholding
methods (see Supplemental Materials and Methods) and image
analysis software enabled segregation of the liver lobule into
branch points (Fig. 3), hepatocytes, nuclei, and vessels (Fig. 4).
The nuclei and branch points were used as an indirect measure
of the number of hepatocytes and vessels, respectively. Data
Fig. 3. Number and type of branch points moving along the pericentral axis of the liver lobule. A: schematic of the convergence of vessels from the periphery
toward the central vein (left) and branch types (right). B and C: skeletonized lobule (B) and higher-magnification image of a branch point exemplifying a typical
triple branch detected by Image-Pro Plus (C). Scale bar  300 m. D: number of branch points as a function of radial distance. E: relative proportions of branch
points in the liver lobule. Values are means (SD). Three animals were assessed (n  3), with 9 lobules measured per animal, spread across 3 separate tissue
sections for a total of 27 lobules analyzed. Significance was determined by unpaired t test (P  0.05). Data in D were fitted to a linear regression equation and
show significant improvement over an intercept-only model (F test).
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were plotted relative to proximity to the central vein (CV),
where R  0 is the center of the CV. The high collagen content
of the pig lobule allows for easy visualization and separation of
a lobule (Fig. 4B). Within a liver lobule, the center of the CV
was set as the origin. The abundance of blood vessels, hepa-
tocytes, nuclei, and branch points was quantified as a function
of the distance from the CV.
More precisely, skeletonizing and thinning the lobule al-
lowed the identification of vessel branch points, which were
used as indirect measurements of vessel number, allowing
quantification of the change in vessel number over radial
distance. Figure 3A shows a schematic representation of the
convergence of vessels from the periphery toward the CV and
an example of three vs. four or more branch points identified
by Image-Pro Plus software. The numbers of branch points
(Fig. 3D) were fitted to a linear regression curve. The points
after R  0.8 were excluded in the linear regression calcula-
tion, because the diameters of lobule peripheries were hetero-
geneous among tissue sections analyzed, skewing the results
toward the periphery. The R2 of the curve was 0.93, and an F
test determined that this model was significantly better than an
intercept-only model (P  0.001). Results showed that dis-
tance from the CV significantly increased the number of branch
points. An unpaired t test conducted on the proportion of
branch types (Fig. 3E) revealed significantly more triple-
branched points (P  0.001), supporting the convergence
model.
The data also show a decrease in the density of vessels and an
increase in hepatocyte density upon moving from the CV (R  0)
to the periphery (R  1) of the lobule (Fig. 4G). To verify this, the
total area within the radial segments was divided by the sum of
either branch points (for vessels) or nuclei (for hepatocytes) within
those same segments (Fig. 4, H and I). This shows that vessels
drastically decrease (Fig. 4H), whereas hepatocytes slightly in-
crease, in size from the CV toward the periphery (Fig. 4I). Data
were fitted to linear regression equations, and the models were
tested against an intercept-only model using the F test, with P 
0.05 considered statistically significant. A significant (P  0.001
in all cases) improvement over an intercept-only model is ob-
served for Fig. 4, G–I.
Fig. 4. A–F: hematoxylin-eosin-stained sections, with regions of importance annotated. Data were fitted using GraphPad automatic outlier detection; outliers are
displayed in black fill. Scale bars  300 m. G: fraction of total area occupied by hepatocytes (□) and vessels (Œ) as a function of their normalized distance
(R) from the central vein. H: area of vessels per branch point decreased as a function of radial distance. I: area of hepatocytes per nucleus increased. Values are
means (SD). Three animals were assessed (n  3), with 9 lobules measured per animal, spread across 3 separate tissue sections for a total of 27 lobules analyzed.
Data in G–I were fitted to a linear regression equation and show significant improvement over an intercept-only model (F test).
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Model of hepatocytes under pressure mediated by the liver
blood flow. As stated in the INTRODUCTION, the physical changes
in the surface density of vessels, hepatocytes, and branch
points may suggest that the lobule experiences pressure due to
its anatomical ultrastructure. To model this, let us consider a
single isolated vessel in a tissue with blood flowing within it,
which is associated with a pressure gradient. The pressure
inside the vessel is also applied against the vessel wall. Let us
further concentrate on a small longitudinal section of the
cylindrical vessel, such that the pressure inside this section is
constant. From a physics point of view, the vessel is like a
hollow cylinder in which an internal pressure can be defined.
We shall assume that when the vessel is on its own, the
pressure far away from the vessel is null. In this context, it is
possible to demonstrate that the radial stress or radial pressure,
rr (Fig. 5), on the tissue surrounding the vessel can be written
as rr~  Piri⁄r2, where Pi is the internal pressure of the
section of the vessel considered, ri is the radius of the vessel,
and r is the distance from the center of the vessel (6). The
minus sign in the expression of rr indicates a radial compres-
sion with a magnitude that decreases with the radial distance.
Let us assume now that two vessels are next to each other; then
the stress on the hepatocytes between the two vessels will
increase as the distance between the vessels decreases (Fig. 5).
Let us now focus on the variable ri⁄r2 and consider that the
variable r is fixed to a typical value corresponding to the
distance halfway between vessels. In this context, one shall
define by r* this typical value. The variable defined by ri⁄r*2
is then the surface density of vessels in the tissue or, similarly,
the concentration of vessels in two dimensions. Therefore,
provided that the pressure inside the vessels is constant, the
higher the density of vessels, the higher the stress applied to
hepatocytes between vessels. Of course, vessels are not neces-
sarily parallel to each other, as shown schematically in Fig. 5,
but this does not rule out the key conclusion that the density of
vessels, whatever their orientations, defines the pressure ap-
plied to hepatocytes between vessels.
Naturally, when considering the blood flow in vessels in the
liver, the pressure Pi will vary along the vessels, being higher
at the periphery and smaller at the center of the lobule. In
addition, if the density of vessels changes from the periphery of
the lobule to the CV, then, by noting R, the radial distance from
the CV, the radial stress becomes a function of this new
parameter and can be rewritten as rrR~  PiRR,
where R represents the density of vessels at the radial
position R. Although the detailed and accurate knowledge of
the three-dimensional ultrastructure of vessels in a lobule down
to a scale of a few micrometers, similar to the size of hepato-
cytes, is still missing and, as a result, it is not possible to
estimate with precision the variable defined by PiR, two
important results suggest that hepatocytes experience a com-
pression toward the CV. The first result concerns the variable
R, which can be estimated experimentally by the percentage
of vessel area as given in Fig. 4, G and H, and increases toward
the CV. The second result is that if the hepatocytes experience
a compression, it is expected that their surface area would be
smaller. This latter point is shown experimentally in Fig. 4, G
and I, demonstrating that the surface area of hepatocytes is
smaller close to the CV.
Despite these limitations, it is still possible to estimate a
ratio for the radial stresses. Indeed, for hepatocytes to experi-
ence a gradient of compression, the product PiRR must
change as a function of the radial position. Using a ratio for the
radial stresses at two different radial locations, i.e., Rmin and







Let us consider Rmax as the radial distance of the lobule




















Fig. 5. A: schematic of radial pressure, rr, as a function of distance from the vessel. For simplicity of representation, the minus sign of the radial pressure has
been omitted. B: if we now assume that 2 vessels are brought close to each other, then the radial pressure between vessels changes and the pressure applied on
hepatocytes between vessels increases. Red dashed lines represent what would be the pressure for a single vessel. With use of notations developed in the text,
the pressure between vessels will be a function of the distance separating vessels: ri⁄r*2. However, ri⁄r*2 can be rewritten as ri2⁄r*2. Given that 
ri2 is the cross-sectional area of the vessel and that r*2 is the surface area occupied by the vessel in the tissue, it follows that ri⁄r*2 is the surface density
of the vessel.
C894 MECHANOSENSITIVITY OF HEPATOCYTE FUNCTIONS
AJP-Cell Physiol • doi:10.1152/ajpcell.00472.2019 • www.ajpcell.org
Downloaded from journals.physiology.org/journal/ajpcell (081.105.037.212) on March 22, 2021.
Fig. 4G, one deduces
Rmin
Rmax




has been estimated using computational fluid dynamic model-




that the radial compression close to the CV increases by ~30%.
It is in this context that pressure was imposed on isolated
hepatocytes.
Effects of pressure on hepatocyte morphology. Hepatocytes
were pressurized in a custom-made pressure plate (Fig. 2) after
an incubation period under pressure or standard culture condi-
tions. The pressure was removed, and the hepatocytes were
imaged on an inverted microscope (Fig. 6). Differences in the
phenotype of hepatocytes were assessed nonquantitatively.
Attention was paid to visual markers of healthy differentiated
hepatocytes: a bright nucleus, clear cell-cell junctions, and no
gaps in the monolayer (44, 54). Hepatocytes in both conditions
retained bright nuclei and a relatively confluent monolayer for
the duration of culture (Fig. 6). On the contrary, cell-cell
borders were most distinct at 6 h and became more difficult to
observe over time. Overall, little difference between the NP
and WP conditions was observed.
Effects of pressure on viability, albumin production, and
protein recovery. To determine if application of hydrostatic
pressure was compatible with long-term hepatocyte culture,
viability via WST-1 and LDH release assays, functionality via
albumin production, and cell loss via protein recovery assays
of hepatocytes in both WP and NP conditions were tested. A
two-way ANOVA on the WST-1 data (Fig. 7A) revealed a
significant difference with time (P  0.004), but not with
pressure (P  0.970) and did not reveal an interaction (P 
0.084). Furthermore, Bonferroni’s post hoc test revealed no
significant difference between the NP and WP groups at each
time point. Thus the viability of hepatocytes (determined by
WST-1 assay) changes with time in culture but is not due to
differences in pressure. Meanwhile, a two-way ANOVA on
albumin production (Fig. 7B) detected significant effects for
time (P  0.001), interaction (P  0.004), and pressure (P 
0.010). Additionally, multiple-comparison testing found a sig-
nificant difference at the 24-h time point (P  0.027), whereas
all other comparisons were not significant (P  0.05). The
LDH release assay (Fig. 7C) showed a small, but significant,
3% change in viability after a 48-h incubation, as determined
by Welch’s unpaired t test (P  0.018). Protein recovery data
(Fig. 7D) were significant, with both time (P  0.001) and
pressure (P  0.001) effects but no interaction. Bonferroni’s
comparison testing of NP with WP at each time point showed
a significant difference between the 6-h NP and WP groups; all
other comparisons were not significant. In summary, although
pressure increases albumin production, it has minimal effect on
the overall viability or protein recovery of cultured hepatocytes
as measured by WST-1, LDH release, and Pierce BCA protein
assays.
Effects of pressure on expression of important absorption,
distribution, metabolism, and excretion genes. The effects of
pressure on a selection of important absorption, distribution,
metabolism, and excretion (ADME) genes were investigated.
Data were normalized to the HPRT housekeeping gene to
generate a CT value and displayed as a 2CT value, with
the NP group at each time point used as the calibrator. A
two-way ANOVA and Bonferroni’s comparison testing were
used to compare NP with WP at each time point using the CT
values. In Fig. 8A, CYP3A4 increases 1.5-fold at 8 h,
decreases to baseline at 24 h, and reaches a significant (P 
0.001) 2-fold reduction in mRNA at 48 h. CYP1A2 (Fig. 8B)
shows a steady increase in mRNA under pressure relative to
the NP control, becoming significant at 8 h (P  0.001) and
maintaining this significance at both 24 and 48 h in culture; the
maximal change of ~10-fold occurs at 24 h. In contrast to
CYP3A4 and CYP1A2, CYP2B6 (Fig. 8C) appears to be
entirely unaffected by pressure application, in that pressure
application neither increases nor decreases the number of
Fig. 6. Bright-field images of hepatocytes after different incubation times with pressure (WP) or without pressure [no pressure (NP)]. Scale bars  200 m.
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mRNA transcripts. CYP2C9 (Fig. 8D), CYP2D6 (Fig. 8E), and
AOX1 (Fig. 8F) generally retain a slightly higher transcript
level under pressure, although the response is highly variable
and not statistically significant. Overall, this points to a
CYP1A2-specific increase under hydrostatic pressure, and in-
vestigation into whether this increase relates to a significant
increase in activity was required.
Pressure improves activity of CYP1A2 in human hepatocytes
and HepaRG and HepG2 cells after 48 h of preincubation with
pressure. P450-Glo, a luminescence-based measure of metab-
olism, was utilized to determine if changes in mRNA translated
to an increase in activity. Human hepatocytes (Fig. 9) were
assessed for differences in the metabolic activity of CYP3A4,
CYP1A2, CYP2C9, and CYP2D6 after 48 h of preincubation
under pressure. Only CYP1A2 demonstrated a significant fold
change under pressure, in agreement with qPCR results. To
verify that the increase in CYP1A2 was not specific to human
primary cells, we also tested HepaRG and HepG2 cells, which
are considered good hepatocyte model cell lines for assessment
of enzyme inductions and have conserved AhR signaling
pathways (27). As such, they are often used to investigate
potential drug-drug interactions (20). CYP1A2 activity was
measured after 48 h of incubation under pressure in both cell
types to determine if the CYP1A2 increase in human hepato-
cytes was retained. The similar significant fold increase in
CYP1A2 response between cell types [~3-fold (P  0.009) in
hepatocytes, ~2-fold (P  0.004) in HepaRG cells, and ~3.6-
fold (P  0.031) in HepG2 cells] suggests that the pressure-
mediated mechanism of CYP1A2 induction is conserved be-
tween hepatic cell types. As both HepaRG and HepG2 cells
retain their AhR signaling and AhR is a known regulator of
CYP1A2, it was investigated for mechanosensitivity.
Effects of AhR agonist and antagonist on the pressure-
mediated increase in CYP1A2 expression and activity. As
CYP1A2 is regulated by a receptor pathway different from the
other CYP isoforms examined, it was hypothesized that the
pressure-induced upregulation of CYP1A2 was mediated by
AhR. To test this theory, pressurized and nonpressurized hepa-
tocytes were incubated with a known AhR inducer, omepra-
zole, as a positive control (33), the AhR antagonist
CH223191 (8, 66), and the vehicle control DMSO. This was
done to show that the AhR pathway remains active in
monolayer culture hepatocytes and to determine if an AhR
antagonist (CH223191) could block or inhibit the pressure-
mediated increase in CYP1A2 expression and activity (Fig. 10,
A and B). Expression changes were highly significant (Fig.
10B), with significant effects of treatment, pressure, and inter-
action (P  0.001), as determined by a two-way ANOVA on
CT values. Bonferroni’s multiple-comparison testing found
significance as follows: a significant fold increase of 9.9 from




















































































Fig. 7. Effects of pressure on viability and functionality of hepatocytes over time. A: results of the water-soluble tetrazolium salt (WST-1) viability assay. OD,
optical density. B: assay of albumin production. Prior to aspiration of medium, a sample of medium was taken and stored at 80°C, and albumin concentration
was determined using a commercial sandwich ELISA kit. C: lactate dehydrogenase (LDH) release after 48 h of incubation with pressure (WP) or without pressure
[no pressure (NP)]. D: percent protein recovery over time, with T0 set as 100%. Values are means (SD) of 3 separate experiments (n  3). For A, B, and D,
significance was determined by 2-way ANOVA and Bonferroni’s multiple-comparison test between pressure groups at each time point. For C, significance was
determined by unpaired t test. *P  0.05 between groups.
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NP vehicle to WP vehicle (P  0.002), showing retention of
pressure-mediated increases in CYP1A2 expression. Omepra-
zole results were as expected [significant increases in expres-
sion: 33.17-fold for NP inducer vs. NP vehicle (P  0.001) and
10.57-fold for WP inducer vs. WP vehicle (P  0.001)], which
showed that hepatocytes cultured in this way retain their AhR
signaling mechanics. The AhR antagonist had a marked effect
on expression, decreasing WP expression by 18.1-fold com-
pared with the vehicle control (P  0.001), while only causing
a nonsignificant 3.3-fold reduction in NP expression with
respect to its vehicle control (P  0.118).
P450-Glo data (Fig. 10C) showed a significant difference
between pressure, interaction, and treatment (P  0.001, P 
0.001, and P  0.017, respectively). Bonferroni’s post hoc test
showed a significant upregulation of WP vehicle compared
with NP vehicle, with a fold change of 2.2 (P  0.027).
Omeprazole caused a significant upregulation from vehicle of
4.1- and 5.2-fold for NP (P  0.001) and WP (P  0.001),
respectively. There was a 4.3-fold change from WP vehicle
to WP coincubated with CH223191 (P  0.001) compared
with a fold change of 1.0 (i.e., no change) between NP vehicle
and NP coincubated with CH223191 (P  0.999).
Furthermore, to confirm the results, a luciferase-transfected
AhR reporter HepG2 cell line (DRE-1A2) was also used to
assess whether AhR was activated in response to pressure.
DMSO vehicle and omeprazole were used as negative and
positive controls, respectively.
For CYP1A2 activity (Fig. 10D), one-way ANOVA showed
significant differences between treatment groups (P  0.006),
and Bonferroni’s adjusted t test showed significant differences

































































































































































































Fig. 8. Effects of pressure on expression of 6 absorption, distribution, metabolism, and excretion (ADME) genes: cytochrome P-450 (CYP) 3A4 (A), CYP1A2
(B), CYP2B6 (C), CYP2C9 (D), CYP2D6 (E), and aldehyde oxidase 1 (AOX1; F). WP, with pressure; NP, without pressure [no pressure (NP)]; HPRT HK,
hypoxanthine-guanine phosphoribosyltransferase 1 housekeeping gene. Values are means (SD); n  3, except CYP2D6 (n  2). *P  0.05 between CT values
(by 2-way ANOVA and Bonferroni’s post hoc test).
Fig. 9. Metabolism of luminescent substrates by primary human
hepatocytes (PHH) after 48 h of preincubation without pressure
[no pressure (NP)] or with pressure (WP). To confirm upregu-
lation of cytochrome P-450 (CYP) 1A2 (CYP1A2) activity in
human hepatocytes and test potential involvement of aryl hy-
drocarbon receptors (AhR), CYP1A2 activity was measured in
both HepaRG and HepG2 cell lines. Values are means (SD) of
2–3 repeats; n  3 for CYP1A2 and n  2 for all other
isoforms. *P  0.05 (by unpaired t test).
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for NP vs. omeprazole (P  0.005) and NP vs. WP (P 
0.014). Lastly, for AhR activation (Fig. 10E), one-way
ANOVA showed significant differences between treatment
groups (P  0.001), with Bonferroni’s adjusted t test revealing
significant differences of ~13-fold for NP vs. omeprazole (P 
0.001) and ~4-fold for NP vs. WP (P  0.011).
Together, these results demonstrate that the application of


























































































































Fig. 10. A: overview of experimental design. Unlike tetrachlorodibenzodioxin (TCDD), omeprazole binds to the aryl hydrocarbon receptor (AhR) with only
moderate potency; it also exhibits none of the toxic side effects of TCDD (46). CH223191 is a potent antagonist that blocks AhR activation. The molecular
mechanism remains unknown, but it is thought that binding of CH223191 either prevents dissociation of the inhibitory complex or covers the nuclear localization
signal (NLS), blocking nuclear translocation. CH223191 at 10 M also had no effect on cell viability in HepG2 cells (9, 66). XAP2, hepatitis B virus X-associated
protein 2. B and C: relative change in expression of CYP1A2 (B) or CYP1A2 metabolism (C) in hepatocytes preincubated with pressure (WP) or without pressure
[no pressure (NP)] and treated with DMSO (vehicle), omeprazole (50 M), or CH223191 (10 M) for 48 h. Values are means (SD) of 3 repeats (n  3). D and
E: activity of CYP1A2 and activation of AhR in a luciferase reporter cell line. Values are means (SD) of 3 repeats (n  3). *P  0.05 vs. NP vehicle, 	P 
0.05 vs. WP vehicle (by Bonferroni’s post hoc test). Data in C were log-transformed to meet variance and normality requirements of statistical tests, but linear
data are displayed.
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AhR signaling pathway, which results in a significant upregu-
lation of CYP1A2 expression and activity. Furthermore, this
increase is abolished by addition of the AhR antagonist
CH223191, implicating AhR in this novel mechanosensitive
signaling pathway.
DISCUSSION
Could vessel organization in the liver lobule impose pres-
sure on hepatocytes? The apparent density (Fig. 4G) and
surface area (Fig. 4H) of vessels increase by ~10% and 250%,
respectively, from the periphery toward the central vein. This
suggests that unless the relative blood pressure within sinusoi-
dal vessels drops to a similar extent, a radial pressure will build
up, compressing the hepatocyte plates. However, it has been
suggested that the drop in pressure between the periphery and
the central vein is 
15–20% (14), suggesting, in turn, that one
order of magnitude (10) is missing, indicating that a com-
pression of the plates may occur. On these premises, the model
shown in Fig. 5, which indicates a compression of hepatocytes
between vessels, was suggested. Although bile contractility
was reported by Oshio and Phillips (48) and, more recently, by
Meyer et al. (39), the model presented in the present study
could also provide a mechanical reason for bile flow in the
opposite direction of blood flow. The accepted theory is that
ions released into the bile duct move the bile via osmosis (4).
Nevertheless, there are other possible explanations: a gradient
of compression of hepatocyte plates being greater around the
central vein and less toward the periphery could press against
the bile duct from the center to the periphery, generating a
physical stress and allowing the bile to flow in the opposite
direction of blood flow.
Finally, differences between peripheral and pericentral sinu-
soids have been observed in rat and mouse liver. It has been
reported that the size of the sinusoidal vessels increases toward
the central vein (10, 32, 46, 64); these data are summarized in
Table 1 and are in good agreement with our data.
Hydrostatic pressure effects on morphology, viability, and
functionality. Our method of applying hydrostatic pressure,
which utilized a gas-permeable membrane, allowed the nega-
tion of hypoxia, a variable that is sometimes overlooked in
other pressure application methods (36). Based on calculations
published previously (50) and reports that hypoxia reduces the
expression of both AhR and CYP1A2, in addition to most other
CYP isoforms (22, 42, 61, 65), and with use of a gas-permeable
membrane that allows O2 to diffuse directly to the cellular
monolayer, we could rule out hypoxia as the reason for the data
collected. Interestingly, pressure does not appear to affect
overall cell morphology and viability, as seen in bright-field
images (Fig. 6) and WST-1 assays (Fig. 7A). Although a small
statistically significant increase (3%) in LDH production was
detected between the WP and NP groups (Fig. 7C), it is
unlikely that the increase is biologically significant. Addition-
ally, it is not known whether pressure itself impacts LDH
production or secretion.
Albumin production is a common method for determining
hepatocyte functionality. Albumin production was better main-
tained in the WP than NP hepatocytes (Fig. 7B). While there is
no measure of albumin production in hepatocytes under hy-
drostatic pressure in the literature, a number of studies that
used shear stress within microfluidic devices or bioreactors
demonstrated increases in albumin production with flow rate/
shear stress (11, 17, 19). Overall, these results, like ours,
suggest that hepatocyte functionality improves after the appli-
cation of in vivo mechanical forces.
In conclusion, the seeming equivalence in phenotype and
minimal change in viability, as determined by WST-1 and
LDH release assays, along with the improved maintenance of
albumin production in hepatocytes cultured under pressure, led
us to conclude that long-term culture of hepatocytes in the
pressure system, both with and without pressure, had no
negative effects. The effects of hydrostatic pressure on the
viability of various cell types have been assessed, and the
results are mixed. In bladder smooth muscle cells, viability
improved under 0.75- to 4-kPa pressure (15, 16, 25), whereas
no detectable difference was observed in human retinal cells
subjected to similar pressure (47). In contrast, some researchers
reported reductions in cell viability under pressure, although
the pressure applied was four times (4 kPa) that used in this
study (30). Whether these discrepancies were due to the use of
different species/cell types and/or methods is not known;
however, a review of the various methods commonly used to
apply hydrostatic pressure has shown differences in cell pro-
liferation and viability due to cell type and amount loaded (38).
Hydrostatic pressure: CYP expression and activity. The
mRNA expression of five CYP isoforms and AOX1, which are
heavily involved in drug metabolism, was assessed. CYP3A4
showed a twofold decrease in mRNA after a 48-h incubation
under pressure, while earlier time points showed little differ-
Table 1. Summary of parameters measured in different species
Species Parameter PP PV Fold Increase PV/PP Reference
Rat Diameter, m 6.4 8.3 1.30 32
Velocity, mm/s 0.2 0.5 2.41
Mouse Diameter, m 8.8 13.7 1.56 64
Rat %Area occupied by sinusoids 26.5 38.5 1.45 10
%Area occupied by lumen 5.5 13.0 2.36
Rat Total SA, m2 50,767 85,155 1.68 46
Mean SA, m2 23,163 41,301 1.78
Total HA, m2 370,431 337,165 0.91
Sinusoidal perimeter, m2 24,909 36,410 1.46
Pig HA/nuclei, m2/nuclei 190.1 170.5 0.90 Present data
Vessel area/BP, m2/BP 12.1 28.1 2.33
%Area occupied by sinusoids 10.1 19.3 1.92
%Area occupied by hepatocytes 89.9 80.7 0.90
SA, sinusoidal area; HA, hepatocyte area; BP, branch point; PP, periportal; PV, perivenous.
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ence (Fig. 8A). CYP1A2 showed what appeared to be an
inductive response to pressure, increasing ~10-fold after 24 h
(Fig. 8B) and maintaining this level at the 48-h point. It should
be noted that CYP3A4 and CYP2D6 in culture are known to
experience a rapid initial decrease until 48 h, at which point an
upturn in activity and expression usually begins (35). It is also
noted that the other CYP isoforms generally decline, but with
no subsequent upturn (29, 35). Our results show that CYP2B6
(Fig. 8C) followed the expected pattern, but CYP1A2 and, to a
much lesser extent, CYP2C9 (Fig. 8D) maintained reasonably
steady rates of activity and expression before an upturn. How-
ever, we found that only CYP1A2 showed a robust and
reproducible induction of mRNA expression and activity in
response to hydrostatic pressure, while CYP3A4 showed a
small decrease in mRNA expression. A possible explanation
for the downregulation of CYP3A4 is the possibility of nega-
tive cross talk between AhR and pregnane X receptor (PXR).
Indeed, it has been observed that coincubation of AhR ligands
and rifampicin reduces rifampicin-mediated CYP3A4 expres-
sion in HepaRG cells and human hepatocytes and that siRNA
knockdown of AhR increases basal CYP3A4 expression (52).
This suggests that the upregulation of AhR, which controls
CYP1A2 expression, has a negative cross-talk effect on PXR,
which regulates CYP3A4 (52). This could explain the down-
regulation of CYP3A4.
To assess whether the change in CYP1A2 mRNA also leads
to functional increases in CYP activity, P450-Glo was em-
ployed to assess changes in activity. Hepatocytes and HepaRG
and HepG2 cells exhibited significant increases in activity
when preincubated under pressure for 48 h (Table 2). Although
there are no data in the literature on the effects of hydrostatic
pressure on CYP expression and activity in hepatocytes, mi-
crofluidic applications have yielded similar results (11, 17, 19,
28, 41, 53, 60).
Hydrostatic pressure improves expression and activity of
CYP1A2 via an AhR-mediated mechanism. The isoform-spe-
cific increase in CYP1A2 expression, while the other drug-
metabolizing isoforms were mostly unaffected (Fig. 9), led to
the conclusion of differential regulation. As CYP1A2 is regu-
lated differently from the other CYP isoforms, it is under the
control of AhR, while others are controlled by PXR, constitu-
tive androstane receptor, or a combination of these regulators
(40). To determine if AhR was responsible for the differences,
we devised a form of induction assay that involved testing the
traditional in vitro inducer (omeprazole), an AhR antagonist
(CH223191), and vehicle control for changes in expression and
activity.
As expected from previous data, the WP vehicle group
results were significantly higher for both expression (~10 fold)
and activity (~2 fold). Also, as expected, omeprazole induced
both CYP1A2 gene expression and activity levels and func-
tioned as a positive control in the assay. Also, the AhR
inhibitor (CH223191) virtually abolished the pressure-medi-
ated expression and activity effect, whereas there was no
significant change in NP expression or activity in the presence
of the AhR inhibitor.
A HepG2 cell line stably transfected with a luciferase-linked
AhR (DRE-1A2) promoter was also used to assess the activa-
tion of the receptor. The prototypical in vitro inducer omepra-
zole was also added as a positive control to prove that the
genetically modified cell lines retained their induction capabil-
ity. These results confirmed that pressure was capable of
activating AhR signaling and upregulating CYP1A2 activity.
One tentative explanation for the specific effect of pressure
on AhR is that the -catenin/Wnt pathway is thought to interact
with and potentially comodulate AhR (24). The mechanosen-
sitivity of AhR could be due to its interaction with the
-catenin/Wnt pathway via the nongenomic pathway (34) and,
not necessarily, direct activation. The complex interaction
between AhR and -catenin/Wnt has been alluded to on
numerous occasions (5, 24, 51). Further work would be needed
to clarify the exact signaling mechanisms involved. Further-
more, the involvement of AhR could have wider implications,
including increasing the expression of phase II metabolic
enzymes, such as UDP-glucuronosyltransferases, and trans-
porters, such as organic anion-transporting polypeptide 1B1
(40).
Shear stress experiments: is shear force impacting the cells?
There is no literature relating AhR induction to hydrostatic
pressure, although there is some evidence that microfluidics
upregulate AhR (9, 41). It is possible, therefore, that the
upregulation was due to the incidental addition of hydrostatic
pressure in the shear stress experimental design or that hepa-
tocytes sense simply a force, rather than being specifically
shear stress-sensitive.
Shear stress experiments involving hepatocytes have often
reported CYP1A2 expression and/or activity and albumin pro-
duction among their major findings (11, 17, 19, 28, 41, 53, 60).
However, often hepatocytes are enclosed in collagen sandwich
configurations, which typically use collagen at 1–3 mg/mL (11,
18). Collagen at these concentrations has a shear strength of
50550 dyn/cm2, meaning that it is able to completely resist
the shearing force of anything 50 dyn/cm2 (at 1 mg/mL
overlay concentration) (57).
This shear strength of collagen is often many times higher
than the shear stress applied in these studies; thus it is possible
that the improvements observed in these experiments are due to
the penetration of drug compounds, movement of toxic com-
pounds away from the cells, or other effects of flowing media,
rather than application of shear stress to the cells. Furthermore,
it has been argued that there might be inadvertent introduction
of hydrostatic pressure within the system; this is easiest to
visualize in pumps that use hydrostatic pressure to drive fluid
motion (45, 62) but is quite possible in other setups (38). In
these setups, it is possible that hydrostatic pressure is applied at
magnitudes many times greater than the shearing force (com-
monly used shearing force is 0.6 dyn/cm2, which equates to
just 6e5 kPa), whereas a pump positioned just 10 cm above
the cell could apply ~1-kPa pressure.
Conclusion. Although the underprediction of hepatic meta-
bolic clearance by hepatocyte cultures is well known, there has
recently been a renewed focus on discovering the cause. With
Table 2. Increase in CYP1A2 metabolism under pressure
Cell Type Fold Change P Value
PHH 3.0 0.009
HepaRG 2.0 0.004
HepG2 (WT) 4.3 0.031
DRE-1A2 3.7 0.017
CYP1A2, cytochrome P-450 1A2; PHH, primary human hepatocytes.
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the advent of microfluidic systems, the effects of mechanical
forces on hepatocyte phenotype and expression have taken
center stage. The results presented here demonstrate that a
mechanical force, in this case hydrostatic pressure, can activate
AhR and upregulate CYP1A2, while having beneficial effects
on albumin production and minimal impact (negative or oth-
erwise) on cellular viability. These findings are important,
because they describe a new and novel link between hydro-
static pressure and the control of CYP metabolism and rein-
force the limitations of standard two-dimensional cultures for
drug clearance prediction and highlight a key improvement
opportunity by introducing aspects of hepatic physiology.
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